Alan Collis

Alan Collis is a seasoned consultant specializing in preclinical and early clinical development, with extensive experience in drug discovery and development. They have led teams through multiple clinical phases, including the successful transition of 33 novel small molecules through preclinical evaluation. Previously serving as Executive Director for DMPK at FORMA Therapeutics and holding leadership roles at Pfizer, Rhône Poulenc Rorer, and Novartis, Alan has demonstrated a strong ability to mentor and coach within the pharmaceutical industry. Currently, as a Senior Consultant at Development Insights, they continue to drive progress in preclinical disciplines across various therapeutic areas. Alan earned both a PhD and a BSc (Hons) in Chemistry from the University of Manchester Institute of Science and Technology.